Mental Health DailyResearch. Evidence. Perspective.Published research on Schizophrenia.
Vraylar (Cariprazine) was approved by the FDA on September 17, 2015 for the treatment of schizophrenia and mania associated with bipolar disorder. In clinical trials, the drug was referenced…
Read articleIt is estimated that over 2.5 million adults in the United States have been diagnosed with schizophrenia; this equates to approximately 1.1% of the population. There are many different types…
Read articleRexulti (Brexpiprazole) is a drug that was approved July 10, 2015 for the treatment of schizophrenia and as an adjunctive option for major depressive disorder. In clinical trials it was refe…
Read articleAntipsychotics are drugs that alleviate symptoms of schizophrenia and psychotic episodes. These medications are considered highly effective interventions for mitigating “positive symptoms” s…
Read articleDelusions of persecution refer to false beliefs or perceptions in which a person believes that they are being treated with malicious intent, hostility, or harassment – despite significant ev…
Read articleDelusions of grandeur are false beliefs held by an individual in which they believe with full conviction that they are a celebrity, person of high rank, omnipotent, and/or a powerful entity …
Read articlePsychosis is a condition that is commonly associated with the mental illness schizophrenia. It is defined as a detachment from reality and hallmark symptoms include delusions (beliefs that a…
Read article